Date published: 2025-11-2

1-800-457-3801

SCBT Portrait Logo
Seach Input

KF 38789 (CAS 257292-29-8)

0.0(0)
Write a reviewAsk a question

See product citations (1)

Alternate Names:
3-[7-(2,4-dimethoxyphenyl)-1,4-thiazepan-5-ylidene]-6-methylpyran-2,4-dione
Application:
KF 38789 is an inhibitor of P-selectin-mediated cell adhesion
CAS Number:
257292-29-8
Purity:
≥97%
Molecular Weight:
375.44
Molecular Formula:
C19H21NO5S
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

KF 38789 is a potent and selective inhibitor of phosphodiesterase 4 (PDE4), an enzyme critical in the breakdown of cyclic adenosine monophosphate (cAMP) within cells. By inhibiting PDE4, KF 38789 leads to an increase in cAMP levels, which plays a pivotal role in modulating cellular responses to various stimuli, including inflammatory and immune responses. This mechanism of action makes KF 38789 useful in research focused on understanding the regulation of cAMP in various cellular processes, including inflammation, cell proliferation, and differentiation. Its selectivity for PDE4 over other phosphodiesterase isoenzymes allows for more precise investigations into the specific roles of PDE4 in cellular signaling pathways, providing insights into the underlying mechanisms of a wide range of physiological and pathological processes. Consequently, KF 38789 is widely used in the study of diseases characterized by dysregulated cAMP signaling pathways, facilitating the exploration of novel therapeutic targets and the development of cAMP-based strategies for disease modulation.


KF 38789 (CAS 257292-29-8) References

  1. Inhibitors of membrane receptors involved with leukocyte extravasation.  |  Bendas, G. 2005. Mini Rev Med Chem. 5: 575-84. PMID: 15974935
  2. Hepatic sinusoidal endothelium avidly binds platelets in an integrin-dependent manner, leading to platelet and endothelial activation and leukocyte recruitment.  |  Lalor, PF., et al. 2013. Am J Physiol Gastrointest Liver Physiol. 304: G469-78. PMID: 23257923
  3. Differential MSC activation leads to distinct mononuclear leukocyte binding mechanisms.  |  Kota, DJ., et al. 2014. Sci Rep. 4: 4565. PMID: 24691433
  4. Linking phenotypes and modes of action through high-content screen fingerprints.  |  Reisen, F., et al. 2015. Assay Drug Dev Technol. 13: 415-27. PMID: 26258308
  5. Vacuolin-1 inhibits autophagy by impairing lysosomal maturation via PIKfyve inhibition.  |  Sano, O., et al. 2016. FEBS Lett. 590: 1576-85. PMID: 27135648
  6. Tubulin is a molecular target of the Wnt-activating chemical probe.  |  Fukuda, Y., et al. 2016. BMC Biochem. 17: 9. PMID: 27207629
  7. Co-targeting the tumor endothelium and P-selectin-expressing glioblastoma cells leads to a remarkable therapeutic outcome.  |  Ferber, S., et al. 2017. Elife. 6: PMID: 28976305
  8. Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells.  |  Wong, KHK., et al. 2017. Nat Commun. 8: 1733. PMID: 29170510
  9. An image-based small-molecule screen identifies vimentin as a pharmacologically relevant target of simvastatin in cancer cells.  |  Trogden, KP., et al. 2018. FASEB J. 32: 2841-2854. PMID: 29401610
  10. Fucoidan-Doxorubicin Nanoparticles Targeting P-Selectin for Effective Breast Cancer Therapy.  |  Jafari, M., et al. 2020. Carbohydr Polym. 249: 116837. PMID: 32933681
  11. P-selectin axis plays a key role in microglia immunophenotype and glioblastoma progression.  |  Yeini, E., et al. 2021. Nat Commun. 12: 1912. PMID: 33771989
  12. Marine Polysaccharides as a Versatile Biomass for the Construction of Nano Drug Delivery Systems.  |  Sun, Y., et al. 2021. Mar Drugs. 19: PMID: 34208540
  13. Pharmacological targeting of the tumor-immune symbiosis in glioblastoma.  |  Pang, L., et al. 2022. Trends Pharmacol Sci. 43: 686-700. PMID: 35534356

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

KF 38789, 10 mg

sc-203617
10 mg
$291.00